Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis
Crossref DOI link: https://doi.org/10.1007/s10096-016-2796-4
Published Online: 2016-09-29
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pang, Y.-k.
Ip, M.
You, J. H. S.
Funding for this research was provided by:
None
License valid from 2016-09-29